ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
May 11, 2026 04:00 ET | Source: ENA Respiratory MELBOURNE, Australia, May…
Apollo Hospitals introduces first of its kind advanced bone regeneration solution for diabetic and complex bone infections
Aims to reduce amputations and improve recovery outcomes for high-risk patientsHYDERABAD, India,…
PIVOT-PO Phase 3 Data Show Tebipenem HBrs Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint…
